![](/images/graphics-bg.png)
PMC-12, a Prescription of Traditional Korean Medicine, Improves Amyloid β -Induced Cognitive Deficits through Modulation of Neuroinflammation
Joint Authors
Choi, Byung Tae
Park, Min Young
Jung, Yeon Suk
Park, Jung Hwa
Choi, Young Whan
Lee, Jaewon
Kim, Cheol Min
Baek, Jin Ung
Shin, Hwa Kyoung
Source
Evidence-Based Complementary and Alternative Medicine
Issue
Vol. 2015, Issue 2015 (31 Dec. 2015), pp.1-10, 10 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2015-04-07
Country of Publication
Egypt
No. of Pages
10
Main Subjects
Abstract EN
PMC-12 is a prescription used in traditional Korean medicine that consists of a mixture of four herbal medicines, Polygonum multiflorum, Rehmannia glutinosa, Polygala tenuifolia, and Acorus gramineus, which have been reported to have various pharmacological effects on age-related neurological diseases.
In the present study, we investigated whether PMC-12 improves cognitive deficits associated with decreased neuroinflammation in an amyloid-β-(Aβ-) induced mouse model and exerts the antineuroinflammatory effects in lipopolysaccharide-(LPS-) stimulated murine BV2 microglia.
Intracerebroventricular injection of A β 25 - 35 in mice resulted in impairment in learning and spatial memory, whereas this was reversed by oral administration of PMC-12 (100 and 500 mg/kg/day) in dose-dependent manners.
Moreover, PMC-12 reduced the increase of Aβ expression and activation of microglia and astrocytes in the A β 25 - 35 -injected brain.
Furthermore, quantitative PCR data showed that inflammatory mediators were significantly decreased by administration of PMC-12 in Aβ-injected brains.
Consistent with the in vivo data, PMC-12 significantly reduced the inflammatory mediators in LPS-stimulated BV2 cells without cell toxicity.
Moreover, PMC-12 exhibited anti-inflammatory properties via downregulation of ERK, JNK, and p38 MAPK pathways.
These findings suggest that the protective effects of PMC-12 may be mediated by its antineuroinflammatory activities, resulting in the attenuation of memory impairment; accordingly, PMC-12 may be useful in the prevention and treatment of AD.
American Psychological Association (APA)
Park, Min Young& Jung, Yeon Suk& Park, Jung Hwa& Choi, Young Whan& Lee, Jaewon& Kim, Cheol Min…[et al.]. 2015. PMC-12, a Prescription of Traditional Korean Medicine, Improves Amyloid β -Induced Cognitive Deficits through Modulation of Neuroinflammation. Evidence-Based Complementary and Alternative Medicine،Vol. 2015, no. 2015, pp.1-10.
https://search.emarefa.net/detail/BIM-1063582
Modern Language Association (MLA)
Park, Min Young…[et al.]. PMC-12, a Prescription of Traditional Korean Medicine, Improves Amyloid β -Induced Cognitive Deficits through Modulation of Neuroinflammation. Evidence-Based Complementary and Alternative Medicine No. 2015 (2015), pp.1-10.
https://search.emarefa.net/detail/BIM-1063582
American Medical Association (AMA)
Park, Min Young& Jung, Yeon Suk& Park, Jung Hwa& Choi, Young Whan& Lee, Jaewon& Kim, Cheol Min…[et al.]. PMC-12, a Prescription of Traditional Korean Medicine, Improves Amyloid β -Induced Cognitive Deficits through Modulation of Neuroinflammation. Evidence-Based Complementary and Alternative Medicine. 2015. Vol. 2015, no. 2015, pp.1-10.
https://search.emarefa.net/detail/BIM-1063582
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1063582